Hong Kong stock exchange filings reveal that on August 27, China Universal Asset Management Co., Ltd. reduced its holdings in KEYMED BIO-B (02162) by 48,000 shares.

The shares were sold at an average price of HK$78.4010 each, bringing the total transaction value to approximately HK$3.7632 million.

Following this disposal, the fund manager's latest share count in the company stands at 14.892 million shares, which corresponds to a reduced ownership stake of 4.98%.